Recent Advances in Molecular Targets and Treatment of Idiopathic Pulmonary Fibrosis: Focus on TGF&bgr; Signaling and the Myofibroblast

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|16|11|1400-1417

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.16, Iss.11, 2009-04, pp. : 1400-1417

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

c-Ski, Smurf2, and Arkadia as regulators of TGF-β signaling: new targets for managing myofibroblast function and cardiac fibrosis

By Cunnington Ryan H.   Nazari Mansoreh   Dixon Ian M.C.  

Canadian Journal of Physiology and Pharmacology, Vol. 87, Iss. 10, 2009-10 ,pp. : 764-772

NRC Research Press

Access to resources Recommend Favorite

Natural Products and Transforming Growth Factor-beta (TGF-&bgr;) Signaling in Cancer Development and Progression

By  

Current Cancer Drug Targets, Vol. 13, Iss. 5, 2013-06 ,pp. : 500-505

Bentham Science Publishers

Access to resources Recommend Favorite

Cytokines and Invertebrates: TGF-&bgr; and PDGF

By  

Current Pharmaceutical Design, Vol. 12, Iss. 24, 2006-08 ,pp. : 3025-3031

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of the TGF-&bgr; Superfamily and their Clinical Applications

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 11, 2006-11 ,pp. : 1255-1261

Bentham Science Publishers

Access to resources Recommend Favorite

Oral Tolerance and TGF-&bgr; -Producing Cells

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 5, Iss. 3, 2006-01 ,pp. : 179-190

Bentham Science Publishers

Access to resources Recommend Favorite